NADP (NADP+) Test

Your body runs on a quiet chemical currency that most standard lab panels never measure. NADP+ (nicotinamide adenine dinucleotide phosphate) and its partner NADPH form a redox pair that sits at the center of two of the most consequential processes in your cells: defending against oxidative damage and building the molecules you need to grow, repair, and function. When this system falls out of balance, the effects ripple across virtually every organ.

What makes this marker especially interesting from a prevention standpoint is that NADP+ levels decline with age, and that decline is linked to many of the diseases people fear most: heart disease, neurodegeneration, metabolic dysfunction, and cancer. Measuring where you stand gives you a window into your cellular resilience that no routine blood panel provides.

What NADP+ Actually Does in Your Body

NADP+ is a small molecule, not a protein or hormone. It is made from NAD+ (its close cousin) by an enzyme called NAD kinase, which adds a single phosphate group. That one phosphate changes everything about the molecule's job description. While NAD+ is mainly involved in extracting energy from food, NADP+ and its reduced form NADPH specialize in two distinct roles.

First, NADPH is the universal electron donor for your antioxidant systems. It recharges glutathione and thioredoxin, the two most important molecules your cells use to neutralize reactive oxygen species. Without enough NADPH, those defense systems stall, and oxidative damage accumulates. Second, NADPH provides the chemical energy needed for building fatty acids, cholesterol, and nucleotides (the raw materials for DNA). Every cell that is growing, dividing, or repairing itself draws heavily on NADPH.

There is also a darker side: NADPH serves as the fuel for a family of enzymes called NADPH oxidases, which deliberately generate reactive oxygen species as part of immune signaling. This means the same molecule can be both shield and sword, depending on context. Both too little and too much NADPH can create problems, a pattern researchers describe as the difference between oxidative stress (too little) and reductive stress (too much).

Heart Disease and Cardiovascular Risk

Imbalances in the NADP+/NADPH system are strongly tied to cardiovascular problems, including atherosclerosis, heart failure, and high blood pressure. The connection runs in both directions. When NADPH is depleted, your blood vessels lose their ability to manage oxidative stress, accelerating the damage that leads to plaque buildup. But when NADPH oxidases are overactive, they produce excessive reactive oxygen species inside vessel walls, contributing to the same process from a different angle.

Extracellular NAD+ (the form measurable in blood) has been shown to correlate negatively with C-reactive protein (a statistical measure of how closely two things move together showed r = -0.451), meaning that as systemic inflammation rises, circulating NAD+ tends to fall. Extracellular NAD+ also correlated positively with hemoglobin (r = 0.482), suggesting a link between NAD metabolism and oxygen-carrying capacity.

Aging and Age-Related Disease

One of the most consistent findings in this field is that plasma NADP+ declines significantly as you age. A study measuring plasma levels across adults aged 20 to 87 found clear decreases in both NAD+ and NADP+ over the lifespan, while their reduced forms (NADH and NADPH) actually increased. A separate large-scale metabolomics study identified NADP+ as one of only 14 blood compounds that showed remarkable age-related changes.

This age-related shift in the NADP+/NADPH ratio reflects a broader pattern: as cells age, they lose the ability to maintain the redox balance that keeps antioxidant defenses sharp and biosynthetic pathways running. The downstream consequences touch neurodegenerative diseases (Alzheimer's and Parkinson's), metabolic disorders (diabetes and obesity), cancer, and ischemic stroke.

G6PD Deficiency: A Genetic Vulnerability

The most well-characterized clinical condition linked to NADPH is glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most common enzyme disorder in humans. G6PD is the gatekeeper enzyme for the pentose phosphate pathway, which is the primary source of NADPH in most cells. People with G6PD deficiency cannot produce enough NADPH to protect their red blood cells from oxidative stress. The result is hemolytic anemia, where red blood cells break apart when exposed to certain drugs, infections, or foods.

If you have G6PD deficiency, your baseline NADPH production is compromised at the source. Knowing your NADP+/NADPH status can add context to how well your cells are coping with that genetic bottleneck.

Why Standard Labs Miss This

NADP+ is not included in any standard metabolic panel, complete blood count, or routine screening. The American Heart Association has acknowledged that standardized clinical methods for measuring free NADPH and NADP+ concentrations in cells do not yet exist. The assays that do exist (liquid chromatography-mass spectrometry, enzymatic cycling assays, NMR spectroscopy) are primarily used in research. This is changing as direct-access labs begin offering NAD-family testing, but the field is still early.

One practical consequence is that no major professional society has published formal reference ranges or clinical decision thresholds for NADP+. That does not mean the measurement is useless. It means you should treat it as a trend marker rather than a single diagnostic snapshot, tracking your own trajectory over time rather than comparing against a universal cutpoint.

When Results Can Be Misleading

NADP+ and NADPH are chemically fragile molecules, and this creates real challenges for accurate measurement. NADPH degrades faster than NADH under the same conditions, and its breakdown rate increases with temperature and pH changes. If a blood sample sits too long before processing, or is centrifuged aggressively (longer than 5 minutes or with fast braking), the result may not reflect what was actually circulating in your blood.

A meta-analysis of NADP-family measurements published between 1961 and 2021 found substantial variability between different labs and methods, making it difficult to compare results across different testing services. Storage at 4 degrees Celsius for up to two hours, temperature variation between 0 and 25 degrees, and tourniquet time had no significant effect on results, which is reassuring for typical blood draws.

• Age: plasma NADP+ declines measurably from your 20s through your 80s, so comparing your result to someone decades younger or older is misleading.
• Kidney function: kidney disease alters NAD-pathway metabolite clearance, with eGFR independently affecting serum nicotinamide levels. If your kidney function is impaired, your NADP+ reading may not mean what it appears to.
• Sex: males tend to have higher whole-blood NAD+ than females before age 50, though NADP+-specific sex differences are less well characterized.
• Acute inflammation: C-reactive protein levels correlate inversely with circulating NAD+ metabolites, so a reading taken during or shortly after an illness may be artificially low.

Tracking Your Trend

Because no universal reference ranges exist for NADP+, and because the molecule's levels shift with age, illness, and metabolic state, a single measurement tells you relatively little. What matters is your trajectory. Get a baseline reading, then retest in 3 to 6 months, especially if you are starting an NAD-precursor supplement, changing your exercise habits, or making dietary shifts.

After establishing your personal baseline, annual retesting lets you catch age-related declines early and measure whether your interventions are actually working. Use the same lab and assay method each time to avoid the cross-method variability that plagues this measurement. A study tracking NAD+ levels over 100 days found relatively stable baselines in the same individuals, suggesting that meaningful changes in your number are real signals, not just noise.

If you are supplementing with an NAD+ precursor like nicotinamide riboside or NMN, tracking your NADP+ alongside NAD+ gives you a more complete picture. NAD kinase converts NAD+ into NADP+, so boosting the upstream supply does not guarantee that the downstream pool follows. Your NADP+ trend tells you whether the extra NAD+ is actually reaching the pathways that matter for antioxidant defense and cellular repair.